RISDIPLAM for Neuromyopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where RISDIPLAM was used for Neuromyopathy.
Most Reported Side Effects for RISDIPLAM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 324 | 9.0% | 0 | 2 |
| Diarrhoea | 280 | 7.7% | 1 | 37 |
| Asthenia | 209 | 5.8% | 3 | 27 |
| Pneumonia | 182 | 5.0% | 50 | 111 |
| Death | 165 | 4.6% | 165 | 18 |
| Pyrexia | 152 | 4.2% | 11 | 55 |
| Fatigue | 145 | 4.0% | 0 | 15 |
| Muscular weakness | 125 | 3.5% | 1 | 15 |
| Vomiting | 121 | 3.3% | 4 | 48 |
| Drug ineffective | 115 | 3.2% | 3 | 7 |
| Headache | 104 | 2.9% | 0 | 11 |
| Covid-19 | 103 | 2.9% | 14 | 41 |
| Rash | 97 | 2.7% | 4 | 12 |
| Nausea | 90 | 2.5% | 1 | 25 |
| Product dose omission issue | 86 | 2.4% | 1 | 16 |
Other Indications for RISDIPLAM
Spinal muscular atrophy (2,744)
Product used for unknown indication (817)
Muscle atrophy (38)
Muscular dystrophy (7)